REVBW logo

Revelation Biosciences (REVBW) Cash From Operations

Annual CFO

-$18.32 M
-$11.03 M-151.45%

December 31, 2024


Summary


Performance

REVBW Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREVBWcash flowmetrics:

Quarterly CFO

-$3.75 M
+$5.51 M+59.52%

December 31, 2024


Summary


Performance

REVBW Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREVBWcash flowmetrics:

TTM CFO

-$18.32 M
-$1.74 M-10.53%

December 31, 2024


Summary


Performance

REVBW TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREVBWcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

REVBW Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-151.4%+59.5%-10.5%
3 y3 years-65.2%+59.5%-10.5%
5 y5 years-+59.5%-10.5%

REVBW Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-151.4%at low-87.1%+59.5%-814.8%at low
5 y5-year-151.4%at low-87.1%+59.5%-814.8%at low
alltimeall time-151.4%at low-87.1%+59.5%-814.8%at low

Revelation Biosciences Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$18.32 M(+151.4%)
-$3.75 M(-59.5%)
-$18.32 M(+10.5%)
Sep 2024
-
-$9.26 M(+273.5%)
-$16.58 M(+126.5%)
Jun 2024
-
-$2.48 M(-12.7%)
-$7.32 M(+51.2%)
Mar 2024
-
-$2.84 M(+41.7%)
-$4.84 M(+141.7%)
Dec 2023
-$7.29 M(-35.1%)
-$2.00 M(-46.0%)
-$2.00 M(-85.3%)
Dec 2022
-$11.22 M
-
-
DateAnnualQuarterlyTTM
Jun 2022
-
-$3.71 M(-23.2%)
-$13.65 M(+0.9%)
Mar 2022
-
-$4.83 M(+67.8%)
-$13.54 M(+22.1%)
Dec 2021
-$11.09 M
-$2.88 M(+28.8%)
-$11.09 M(+35.1%)
Sep 2021
-
-$2.23 M(-37.8%)
-$8.21 M(+37.4%)
Jun 2021
-
-$3.59 M(+50.9%)
-$5.98 M(+150.9%)
Mar 2021
-
-$2.38 M
-$2.38 M

FAQ

  • What is Revelation Biosciences annual cash flow from operations?
  • What is the all time high annual CFO for Revelation Biosciences?
  • What is Revelation Biosciences annual CFO year-on-year change?
  • What is Revelation Biosciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Revelation Biosciences?
  • What is Revelation Biosciences quarterly CFO year-on-year change?
  • What is Revelation Biosciences TTM cash flow from operations?
  • What is the all time high TTM CFO for Revelation Biosciences?
  • What is Revelation Biosciences TTM CFO year-on-year change?

What is Revelation Biosciences annual cash flow from operations?

The current annual CFO of REVBW is -$18.32 M

What is the all time high annual CFO for Revelation Biosciences?

Revelation Biosciences all-time high annual cash flow from operations is -$7.29 M

What is Revelation Biosciences annual CFO year-on-year change?

Over the past year, REVBW annual cash flow from operations has changed by -$11.03 M (-151.45%)

What is Revelation Biosciences quarterly cash flow from operations?

The current quarterly CFO of REVBW is -$3.75 M

What is the all time high quarterly CFO for Revelation Biosciences?

Revelation Biosciences all-time high quarterly cash flow from operations is -$2.00 M

What is Revelation Biosciences quarterly CFO year-on-year change?

Over the past year, REVBW quarterly cash flow from operations has changed by +$5.51 M (+59.52%)

What is Revelation Biosciences TTM cash flow from operations?

The current TTM CFO of REVBW is -$18.32 M

What is the all time high TTM CFO for Revelation Biosciences?

Revelation Biosciences all-time high TTM cash flow from operations is -$2.00 M

What is Revelation Biosciences TTM CFO year-on-year change?

Over the past year, REVBW TTM cash flow from operations has changed by -$1.74 M (-10.53%)